Search

Arathi Sundaram Phones & Addresses

  • 776 Lemos Ln, Fremont, CA 94539 (510) 226-6908
  • Troy, NY
  • Alameda, CA

Skills

Medicinal Chemistry

Languages

English

Industries

Pharmaceuticals

Resumes

Resumes

Arathi Sundaram Photo 1

Arathi Sundaram

View page
Location:
447 King Ave, Fremont, CA 94536
Industry:
Pharmaceuticals
Skills:
Medicinal Chemistry
Languages:
English

Business Records

Name / Title
Company / Classification
Phones & Addresses
Arathi Sundaram
Managing
Labyrinth Research, LLC
Medicinal Chemistry Consulting
28570 Fox Holw Dr, Hayward, CA 94542

Publications

Us Patents

N-Formyl Hydroxylamines Compounds

View page
US Patent:
8044199, Oct 25, 2011
Filed:
Jun 2, 2009
Appl. No.:
12/476824
Inventors:
Kathryn Rene Bracken - Swampscott MA, US
Simon Bushell - Boston MA, US
Karl Dean - Marlborough MA, US
Charles Francavilla - Fremont CA, US
Rakesh K. Jain - Fremont CA, US
Kwangho Lee - Lexington MA, US
Mohindra Seepersaud - Belmont MA, US
Lei Shu - Woburn MA, US
Arathi Sundaram - Fremont CA, US
Zhengyu Yuan - Palo Alto CA, US
Assignee:
Vicuron Holdings LLC - New York NY
International Classification:
C07D 403/02
US Classification:
544238
Abstract:
Novel N-formyl hydroxylamine compounds of formula I:.

N-Formyl Hydroxylamines

View page
US Patent:
20080161558, Jul 3, 2008
Filed:
May 22, 2006
Appl. No.:
11/914659
Inventors:
Kathryn Rene Bracken - Swampscott MA, US
Simon Bushell - Boston MA, US
Karl Dean - Marlborough MA, US
Charles Francavilla - Fremont CA, US
Rakesh K. Jain - Fremont CA, US
Kwangho Lee - Lexington MA, US
Mohindra Seepersaud - Belmont MA, US
Lei Shu - Woburn MA, US
Arathi Sundaram - Fremont CA, US
Zhengyu Yuan - Palo Alto CA, US
International Classification:
C07D 403/12
C07D 401/12
US Classification:
544238, 5462791, 544336
Abstract:
Novel N-formyl hydroxylamine compounds and their derivatives are disclosed. These N-formyl hydroxylamine compounds inhibit peptidyl deformylase (PDF), an enzyme present in prokaryotes. The compounds are useful as antimicrobials and antibiotics. The compounds of the invention display selective inhibition of peptidyl deformylase versus other metalloproteinases such as MMPs. Methods of preparation and use of the compounds are also disclosed.

Agonists Of Peroxisome Proliferator Activated Receptor-Alpha

View page
US Patent:
20100184815, Jul 22, 2010
Filed:
Dec 18, 2009
Appl. No.:
12/641954
Inventors:
Gary W. Luehr - Hayward CA, US
Arathi Sundaram - Fremont CA, US
Priya Jaishankar - Hayward CA, US
Chhaya Bhakta - San Ramon CA, US
Pascal Druzgala - Santa Rosa CA, US
International Classification:
A61K 31/4196
C07D 249/12
C07D 249/04
C07D 231/12
A61K 31/4192
A61K 31/415
A61P 9/10
US Classification:
514383, 5482632, 548255, 5483731, 514359, 514406
Abstract:
Disclosed are compounds of the formula:And pharmaceutically acceptable salts thereof, wherein the variables are as defined herein, which are useful in activating PPARĪ± and in treating atherosclerosis hypercholesterolemia, primary hypercholesterolemia or mixed dyslipidemia, hypertriglyceridemia, Frederickson Types IV and V hyperlipidemia. Pharmaceutical compositions, intermediates useful in the preparation of the compounds of formula I and methods of making the compounds of formula I are also disclosed.

D2 Antagonists, Methods Of Synthesis And Methods Of Use

View page
US Patent:
20120010228, Jan 12, 2012
Filed:
Jun 17, 2011
Appl. No.:
13/163592
Inventors:
Gary W. Luehr - Hayward CA, US
Arathi Sundaram - Fremont CA, US
Priyadarshini Jaishankar - Newark CA, US
Philip W. Payne - Sunnyvale CA, US
Pascal Druzgala - Santa Rosa CA, US
International Classification:
A61K 31/438
A61P 25/04
A61P 25/00
C07D 487/10
US Classification:
514278, 546 16
Abstract:
Provided are Dor Dantagonist compounds and pharmaceutical compositions of formula Iand pharmaceutically acceptable salts thereof, or isomers thereof, wherein R, Rand Rare as defined herein. The invention further comprises methods for making the compounds of the invention and methods for the treatment of conditions mediated by the dopamine Dor Dreceptor from the compounds of the invention.

D2 Antagonists, Methods Of Synthesis And Methods Of Use

View page
US Patent:
20140350005, Nov 27, 2014
Filed:
Feb 19, 2014
Appl. No.:
14/184615
Inventors:
GARY W. LUEHR - HAYWARD CA, US
ARATHI SUNDARAM - FREMONT CA, US
PRIYADARSHINI JAISHANKAR - NEWARK CA, US
PHILIP W. PAYNE - SUNNYVALE CA, US
PASCAL DRUZGALA - SANTA ROSA CA, US
International Classification:
C07D 471/10
A61K 31/5377
A61K 31/439
A61K 31/435
A61K 45/06
A61K 31/4545
A61K 31/538
A61K 31/496
US Classification:
5142305, 5142358, 51425309, 514278, 544 70, 544230, 546 16, 546 20
Abstract:
Provided are Dor Dantagonist compounds and pharmaceutical compositions of formula Iand pharmaceutically acceptable salts thereof, or isomers thereof, wherein R, Rand Rare as defined herein. The invention further comprises methods for making the compounds of the invention and methods for the treatment of conditions mediated by the dopamine Dor Dreceptor from the compounds of the invention.
Arathi Te Sundaram from Fremont, CA, age ~57 Get Report